Earnings From Drug Stocks To Watch (HUM, AGN, MNTA)

Humana Inc. (NYSE:HUM) added 0.62% to $58.65. The company said Monday that its third-quarter net profit rose 30% to $393.2 million, or $2.32 a share, from $301.5 million, or $1.78 a share, a year earlier as it also lifted its guidance for the year. Revenue for the quarter rose 9.2% to $8.42 billion. Analysts polled by FactSet Research had been expecting earnings of $1.67 a share on revenue of $8.43 billion. Humana said it now expects earnings for 2010 to be between $6.40 and $6.50 a share. Analysts had been expecting earnings for the year of $6.28 a share. The stock went up more than 32% year-to-date. Allergan, Inc. (NYSE:AGN) surged 1.78% to $73.70. The company said it lost $671 million, or $2.21 a share, compared with a profit of $179 million, or 58 cents a share, for the same period in 2009. Excluding various charges, Allergan would have reported adjusted earnings of 78 cents a share versus 70 cents. Revenue came in at $1.21 billion, up from $1.14 billion. A poll of analysts by FactSet estimated Allergan would earn 77 cents a share, on revenue of $1.18 billion. The company said it now sees 2010 sales coming in between $4.75 billion and $4.8 billion, and adjusted earnings of $3.14 to $3.16 a share. FactSet had pegged earnings of $3.16 a share, on revenue of $4.78 billion. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) fell 4.49% to $15.95. Net income of the company was $32.1 million or $0.70 per share, compared to a net loss of $14.6 million or $0.38 per share, for the same period last year. Analysts expect the company to report earnings of $0.52 per share for the quarter. Analysts' estimates typically exclude special items. Revenue jumped to $52.0 million, from $4.0 million for the same period last year. Six analysts had consensus revenue estimate of $46.83 million for the quarter. At current market price, the market capitalization of the company stands at $722.14 million.
tdp2664
Epic Stock Picks